Herman Ortiz, LVN, CCRC, who is the Clinical Research Manager at Research Specialists of Texas, will discuss with Dr. Galati opportunities for participating in clinical research studies investigating new drugs for hepatitis C.
 
Clinical studies are now underway for patients with hepatitis C who have never been treated, or who in the past have received PEG-interferon and Ribavirin, but who failed to fully clear the virus. All of the studies are being conducted in patients with genoytpe 1 HCV.
 
To contact Herman Ortiz, call Research Specialists of Texas at 713-634-5110.
 
If accepted into a study, all testing, medications, and visits are paid for by the sponsors of the study, with no cost to the patient.